Furthermore, ROC analysis established that CASP1, GLUL, and PYCARD have diagnostic significance for NASH, and PYCARD can also serve as a diagnostic marker for NAFLD progression. This evidence concerns the gene PYCARD and metabolic dysfunction-associated steatotic liver disease.